We are live on ! Find out more
PA

Perceptive Advisors Portfolio holdings

AUM $6.66B
1-Year Est. Return 360.84%
This Fund
S&P 500
This Quarter Est. Return
-16.07%
1 Year Est. Return
+360.84%
3 Year Est. Return
+1,707.27%
5 Year Est. Return
+3,210.42%
10 Year Est. Return
+53,055.89%
AUM
$1.14B
AUM Growth
-$212M
Cap. Flow
+$85.4M
Cap. Flow %
7.49%
Top 10 Hldgs %
46.56%
Holding
206
New
51
Increased
51
Reduced
18
Closed
36

Top Buys

Rank Stock Value
1
SRPT icon
Sarepta Therapeutics
SRPT
+$27.8M
2
HUM icon
Humana
HUM
+$19.1M
3
XLRN
Acceleron Pharma
XLRN
+$15.3M
4
QTNT
Quotient Limited Ordinary Shares
QTNT
+$13.2M
5
MDVN
MEDIVATION, INC.
MDVN
+$12.3M

Top Sells

Rank Stock Value
1
DYAX
DYAX CORPORATION
DYAX
+$68.4M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$12.9M
3
BAX icon
Baxter International
BAX
+$10.1M
4
BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
+$8.54M
5
NVRO
NEVRO CORP.
NVRO
+$8M

Sector Composition

Rank Sector Weight
1 Healthcare 92.87%
2 Consumer Staples 0.6%
3 Consumer Discretionary 0.11%
4 Industrials 0.04%
5 Financials 0.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ITGR icon
176
Integer Holdings
ITGR
$4.26B
– –
-4,817
Closed -$231K
LNTH icon
177
Lantheus
LNTH
$6.59B
– –
-38,784
Closed -$131K
SAGE
178
DELISTED
Sage Therapeutics
SAGE
– –
-20,000
Closed -$1.17M
SRPT icon
179
PUT
Sarepta Therapeutics
SRPT
$1.96B
– –
-100,000
Closed -$3.86M
THC icon
180
Tenet Healthcare
THC
$22.2B
– –
-6,927
Closed -$210K
TTNP
181
DELISTED
Titan Pharmaceuticals
TTNP
– –
-145
Closed -$1.94M
UTMD icon
182
Utah Medical Products
UTMD
$224M
– –
-1,828
Closed -$107K
ASXC
183
DELISTED
Asensus Surgical, Inc.
ASXC
– –
-131,995
Closed -$4.26M
HEWG
184
DELISTED
iShares Currency Hedged MSCI Germany ETF
HEWG
– –
-100,000
Closed -$2.44M
AVGR
185
DELISTED
Avinger, Inc. Common Stock
AVGR
– –
0
– -$444K
ACGN
186
DELISTED
Aceragen Inc
ACGN
– –
-34
Closed -$14K
BLCM
187
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
– –
-42,119
Closed -$8.54M
LHCG
188
DELISTED
LHC Group LLC
LHCG
– –
-3,705
Closed -$168K
LCI
189
DELISTED
Lannett Company, Inc.
LCI
– –
-1,046
Closed -$168K
GWPH
190
PUT
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-400,000
Closed -$27.8M
MDCO
191
DELISTED
Medicines Co
MDCO
– –
-75,000
Closed -$2.8M
CBM
192
DELISTED
Cambrex Corporation
CBM
– –
-4,692
Closed -$221K
EXAC
193
DELISTED
Exactech Inc
EXAC
– –
-10,734
Closed -$195K
SCAI
194
DELISTED
Surgical Care Affiliates, Inc.
SCAI
– –
-5,133
Closed -$204K
ARIA
195
DELISTED
Ariad Pharmaceuticals Inc
ARIA
– –
-50,000
Closed -$313K
AMSG
196
DELISTED
Amsurg Corp
AMSG
– –
-2,243
Closed -$170K
VTAE
197
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
– –
-200,000
Closed -$3.62M
HNT
198
DELISTED
HEALTH NET INC
HNT
– –
-3,831
Closed -$262K
DYAX
199
DELISTED
DYAX CORPORATION
DYAX
– –
-1,819,215
Closed -$68.4M
LPNT
200
DELISTED
LifePoint Health, Inc.
LPNT
– –
-2,862
Closed -$210K
5 6 7
8
9

Similar funds

QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
FCBT
First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return
RWM
Ritholtz Wealth Management New York $6.7B AUM 32.7% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.6B AUM 30.67% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.59B AUM 31.9% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return
MCM
Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return

Perceptive Advisors's Q1 2016 Portfolio in Review

As of Q1 2016, Perceptive Advisors held 206 positions worth $1.14B, down 16% from $1.35B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Perceptive Advisors deployed $85.4M of net new capital in Q1 2016, opening 51 new positions and adding to 51 existing holdings. Its largest new stake was Humana: 110,000 shares worth $20.1M.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, up from 89% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

On the sell side, the largest reduction was Teva Pharmaceuticals, an estimated $12.9M trimmed.

  • Perceptive Advisors's largest Q1 2016 buy was Humana: 110,000 shares worth $20.1M.
  • Perceptive Advisors added most to Sarepta Therapeutics in Q1 2016, an estimated $27.8M increase.
  • Perceptive Advisors's biggest Q1 2016 reduction was Teva Pharmaceuticals, cutting an estimated $12.9M.
  • Perceptive Advisors fully exited DYAX CORPORATION in Q1 2016, selling an estimated $68.4M.
  • Perceptive Advisors's ten largest holdings make up 47% of its $1.14B portfolio in Q1 2016.
  • Perceptive Advisors opened 51 new positions and closed 36 in Q1 2016.
  • Perceptive Advisors's portfolio value fell 16% quarter-over-quarter to $1.14B.

Based on Perceptive Advisors's 13F filing for Q1 2016, filed 16 May 2016.